Financhill
Sell
28

RGR Quote, Financials, Valuation and Earnings

Last price:
$34.93
Seasonality move :
10.06%
Day range:
$34.80 - $35.53
52-week range:
$34.80 - $48.20
Dividend yield:
1.98%
P/E ratio:
20.19x
P/S ratio:
1.18x
P/B ratio:
1.86x
Volume:
576.2K
Avg. volume:
187.9K
1-year change:
-21.73%
Market cap:
$586.5M
Revenue:
$543.8M
EPS (TTM):
$1.73
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $410.5M $568.9M $730.7M $595.8M $543.8M
Revenue Growth (YoY) -17.18% 38.58% 28.45% -18.46% -8.74%
 
Cost of Revenues $311M $377.4M $451.2M $415.8M $410.1M
Gross Profit $99.5M $191.4M $279.6M $180.1M $133.6M
Gross Profit Margin 24.25% 33.65% 38.26% 30.22% 24.57%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $60.1M $72.3M $76.5M $76.7M $81.5M
Other Inc / (Exp) $1.2M $950K $3.7M $2.6M $1.5M
Operating Expenses $60.1M $72.3M $76.5M $76.7M $81.5M
Operating Income $39.4M $119.1M $203M $103.4M $52.1M
 
Net Interest Expenses -- -- $115K -- --
EBT. Incl. Unusual Items $43M $121M $206.6M $108.3M $58.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $10.7M $30.6M $50.7M $19.9M $10.6M
Net Income to Company $32.3M $90.4M $155.9M $88.3M $48.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $32.3M $90.4M $155.9M $88.3M $48.2M
 
Basic EPS (Cont. Ops) $1.85 $5.17 $8.87 $5.00 $2.73
Diluted EPS (Cont. Ops) $1.82 $5.09 $8.78 $4.96 $2.71
Weighted Average Basic Share $17.5M $17.5M $17.6M $17.6M $17.7M
Weighted Average Diluted Share $17.8M $17.8M $17.8M $17.8M $17.8M
 
EBITDA $72.6M $148.7M $232.9M $134.3M $81.4M
EBIT $43.2M $121.2M $206.8M $108.5M $59M
 
Revenue (Reported) $410.5M $568.9M $730.7M $595.8M $543.8M
Operating Income (Reported) $39.4M $119.1M $203M $103.4M $52.1M
Operating Income (Adjusted) $43.2M $121.2M $206.8M $108.5M $59M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $145.7M $178.2M $139.4M $120.9M $122.3M
Revenue Growth (YoY) 53.38% 22.33% -21.8% -13.27% 1.15%
 
Cost of Revenues $94.6M $113.4M $100.5M $96.2M $99.6M
Gross Profit $51.2M $64.8M $38.9M $24.7M $22.7M
Gross Profit Margin 35.11% 36.36% 27.89% 20.46% 18.54%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $18.3M $18.1M $19M $18.4M $18.9M
Other Inc / (Exp) $38K $1.4M $490K $431K $392K
Operating Expenses $18.3M $18.1M $19M $18.4M $18.9M
Operating Income $32.9M $46.7M $19.9M $6.3M $3.7M
 
Net Interest Expenses $2K $103K -- -- --
EBT. Incl. Unusual Items $32.9M $48M $21M $8.1M $5.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $8.1M $12.8M $2.6M $658K $527K
Net Income to Company $24.8M $35.2M $18.4M $7.4M $4.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $24.8M $35.2M $18.4M $7.4M $4.7M
 
Basic EPS (Cont. Ops) $1.42 $2.00 $1.04 $0.42 $0.28
Diluted EPS (Cont. Ops) $1.39 $1.98 $1.03 $0.42 $0.28
Weighted Average Basic Share $17.5M $17.6M $17.7M $17.7M $16.8M
Weighted Average Diluted Share $17.8M $17.8M $17.8M $17.9M $17.1M
 
EBITDA $40.2M $55.4M $27.7M $14.7M $11.1M
EBIT $33M $48.1M $21.1M $8.2M $5.3M
 
Revenue (Reported) $145.7M $178.2M $139.4M $120.9M $122.3M
Operating Income (Reported) $32.9M $46.7M $19.9M $6.3M $3.7M
Operating Income (Adjusted) $33M $48.1M $21.1M $8.2M $5.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $504.7M $732M $614.7M $562.4M $520.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $352.7M $451.6M $410.7M $421.5M $407M
Gross Profit $152M $280.3M $204M $140.9M $113.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $65M $79.9M $75.5M $79.5M $82.9M
Other Inc / (Exp) $789K $3M $3.3M $1.6M $1.2M
Operating Expenses $65M $79.9M $75.5M $79.5M $82.9M
Operating Income $87M $200.4M $128.4M $61.4M $30.6M
 
Net Interest Expenses -- $104K -- -- --
EBT. Incl. Unusual Items $89.2M $203.3M $132.5M $68.5M $36.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $22.4M $53.8M $25M $11.6M $6.4M
Net Income to Company $66.9M $149.5M $107.5M $56.9M $30.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $66.9M $149.5M $107.5M $56.9M $30.3M
 
Basic EPS (Cont. Ops) $3.83 $8.51 $6.11 $3.21 $1.76
Diluted EPS (Cont. Ops) $3.76 $8.42 $6.04 $3.20 $1.73
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $118M $231.4M $157M $94M $56.6M
EBIT $89.5M $203.4M $132.7M $68.7M $36.9M
 
Revenue (Reported) $504.7M $732M $614.7M $562.4M $520.5M
Operating Income (Reported) $87M $200.4M $128.4M $61.4M $30.6M
Operating Income (Adjusted) $89.5M $203.4M $132.7M $68.7M $36.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $399.6M $562.7M $446.6M $413.2M $389.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $272.4M $346.6M $306.1M $311.8M $308.6M
Gross Profit $127.2M $216.1M $140.5M $101.4M $81.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $50.2M $57.8M $56.8M $59.6M $61M
Other Inc / (Exp) $451K $2.5M $2.1M $1.1M $749K
Operating Expenses $50.2M $57.8M $56.8M $59.6M $61M
Operating Income $77M $158.4M $83.8M $41.8M $20.2M
 
Net Interest Expenses $2K $133K $60K -- --
EBT. Incl. Unusual Items $78.4M $160.7M $86.6M $46.8M $24.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $19.7M $42.9M $17.2M $8.8M $4.7M
Net Income to Company $58.7M $117.8M $69.4M $38M $20.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $58.7M $117.8M $69.4M $38M $20.1M
 
Basic EPS (Cont. Ops) $3.36 $6.70 $3.94 $2.14 $1.17
Diluted EPS (Cont. Ops) $3.31 $6.64 $3.90 $2.14 $1.15
Weighted Average Basic Share $52.4M $52.7M $52.9M $53.1M $51.6M
Weighted Average Diluted Share $53.2M $53.3M $53.4M $53.5M $52.4M
 
EBITDA $100.2M $182.8M $106.9M $66.6M $41.8M
EBIT $78.6M $160.8M $86.8M $47M $24.8M
 
Revenue (Reported) $399.6M $562.7M $446.6M $413.2M $389.9M
Operating Income (Reported) $77M $158.4M $83.8M $41.8M $20.2M
Operating Income (Adjusted) $78.6M $160.8M $86.8M $47M $24.8M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $35.4M $20.1M $21M $65.2M $15.2M
Short Term Investments $129.5M $121M $200M $159.1M $102.5M
Accounts Receivable, Net $52.6M $57.9M $57M $65.4M $59.9M
Inventory $28.3M $29.1M $43.9M $65M $79.8M
Prepaid Expenses $3.5M $6.3M -- -- --
Other Current Assets -- -- $6.8M $7.1M $14.1M
Total Current Assets $249.3M $234.4M $328.7M $361.8M $271.4M
 
Property Plant And Equipment $76.5M $70.7M $73.6M $76.9M $71.5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $2.4M $12.6M $12.5M $11.6M $10.9M
Other Long-Term Assets $3.4M $6.8M $9M $11.2M $10M
Total Assets $349M $348.3M $442.3M $484.8M $398.8M
 
Accounts Payable $8.3M $12.8M $12.2M $13.3M $11.1M
Accrued Expenses $10.8M $10M $8.5M $8.7M $8.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $735K $1.1M $795K $235K $634K
Total Current Liabilities $61.2M $81.8M $77.1M $163.1M $63.2M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $63.5M $83.6M $78.7M $168M $67.1M
 
Common Stock $24.2M $24.2M $24.3M $24.4M $24.4M
Other Common Equity Adj -- -- -- -- --
Common Equity $285.5M $264.7M $363.7M $316.7M $331.7M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $285.5M $264.7M $363.7M $316.7M $331.7M
 
Total Liabilities and Equity $349M $348.3M $442.3M $484.8M $398.8M
Cash and Short Terms $164.9M $141.2M $221M $224.3M $117.7M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $29.7M $27.7M $49.9M $13.6M $7.5M
Short Term Investments $104M $165M $165.3M $106.5M $88.5M
Accounts Receivable, Net $58.2M $71.9M $61.4M $59.9M $60.2M
Inventory $13.6M $39.1M $61.5M $79.3M $76M
Prepaid Expenses $7.5M $5.2M $13M -- --
Other Current Assets -- -- -- $14.8M $14.9M
Total Current Assets $213M $308.9M $351M $274M $247.1M
 
Property Plant And Equipment $60.4M $64.5M $71.6M $69.8M $72.5M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $34.9M $46.7M $35.8M $46.4M $38.9M
Total Assets $310.6M $420.1M $460.9M $400.4M $373.5M
 
Accounts Payable $27.6M $38.4M $31.4M $29.7M $31.5M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $959K $870K $434K $406K $270K
Total Current Liabilities $67.4M $80.4M $60.2M $61.2M $55M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $69.3M $82M $62.4M $65M $58.5M
 
Common Stock $24.2M $24.3M $24.4M $24.4M $24.5M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $241.3M $338.1M $398.5M $335.3M $314.9M
 
Total Liabilities and Equity $310.6M $420.1M $460.9M $400.4M $373.5M
Cash and Short Terms $133.6M $192.7M $215.2M $120M $96M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $32.3M $90.4M $155.9M $88.3M $48.2M
Depreciation & Amoritzation $29.3M $27.6M $26.2M $25.8M $22.4M
Stock-Based Compensation $6.3M $6.1M $8.3M $1.7M $4M
Change in Accounts Receivable -$7.6M -$5.2M $840K -$8.4M $5.6M
Change in Inventories $2.1M $10.6M -$15.7M -$21.6M -$16.1M
Cash From Operations $49.6M $143.8M $172.3M $77.2M $33.9M
 
Capital Expenditures $20.3M $24.2M $28.8M $27.7M $15.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$35.4M -$43.9M -$107.5M $13.2M $40.9M
 
Dividends Paid (Ex Special Dividend) -$14.3M -$113.9M -$59.1M -$42.7M -$110.8M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$2M -- -- -$222K -$11.8M
Other Financing Activities -$901K -$1.3M -$4.8M -$3.4M -$2.2M
Cash From Financing -$17.2M -$115.2M -$63.9M -$46.3M -$124.8M
 
Beginning Cash (CF) $38.5M $35.4M $20.1M $21M $65.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$3.1M -$15.3M $897K $44.1M -$50M
Ending Cash (CF) $35.4M $20.1M $21M $65.2M $15.2M
 
Levered Free Cash Flow $29.3M $119.6M $143.6M $49.5M $18.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $24.8M $35.2M $18.4M $7.4M $4.7M
Depreciation & Amoritzation $7.2M $7.3M $6.7M $6.5M $5.8M
Stock-Based Compensation $1.7M $1.6M $1.7M $1M $1.1M
Change in Accounts Receivable -$4.6M $4.2M -$5.1M -$6.8M -$4M
Change in Inventories -$1.5M -$7.1M -$4.4M -$9.9M -$3.2M
Cash From Operations $3.9M $40.8M $17.9M -$4.5M $9.4M
 
Capital Expenditures $2.1M $4.2M $2.9M $6.8M $6.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing $102.9M -$19.1M -$3.2M $13M $3.3M
 
Dividends Paid (Ex Special Dividend) -$94.8M -$17.6M -$8.3M -$6.4M -$3.2M
Special Dividend Paid $5M -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$107K -- -$9.1M
Other Financing Activities -- -- -- -- --
Cash From Financing -$94.8M -$17.6M -$8.4M -$6.4M -$12.3M
 
Beginning Cash (CF) $17.7M $23.6M $43.5M $11.5M $7.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $11.9M $4.1M $6.3M $2.1M $369K
Ending Cash (CF) $29.7M $27.7M $49.9M $13.6M $7.5M
 
Levered Free Cash Flow $1.7M $36.7M $15M -$11.3M $2.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $66.9M $149.5M $107.5M $56.9M $30.3M
Depreciation & Amoritzation $28.5M $27.9M $24.3M $25.2M $19.7M
Stock-Based Compensation $6M $8.4M $6.7M -$414K $4.3M
Change in Accounts Receivable -$2.2M -$13.6M $10.5M $1.5M -$258K
Change in Inventories $18.4M -$14.1M -$23.3M -$18.3M $1.9M
Cash From Operations $122.6M $178.8M $105.6M $44.3M $52.1M
 
Capital Expenditures $19.2M $31.8M $30.4M $22.2M $21.4M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$8.5M -$121M -$30.6M $36.8M -$3.4M
 
Dividends Paid (Ex Special Dividend) -$106M -$55M -$49.4M -$115M -$13M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -$115K -$41.2M
Other Financing Activities -$1.3M -$4.8M -$3.4M -$2.2M -$624K
Cash From Financing -$107.3M -$59.8M -$52.9M -$117.3M -$54.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $6.8M -$2M $22.2M -$36.3M -$6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $103.4M $147M $75.2M $22.1M $30.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $58.7M $117.8M $69.4M $38M $20.1M
Depreciation & Amoritzation $21.6M $22M $20.1M $19.6M $16.9M
Stock-Based Compensation $4.4M $6.7M $5.1M $3M $3.2M
Change in Accounts Receivable -$5.6M -$14M -$4.3M $5.6M -$293K
Change in Inventories $14.7M -$10M -$17.7M -$14.3M $3.7M
Cash From Operations $82M $117M $50.3M $17.3M $35.5M
 
Capital Expenditures $8M $15.6M $17.2M $11.6M $17.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing $17.6M -$59.5M $17.5M $41M -$3.2M
 
Dividends Paid (Ex Special Dividend) -$104.1M -$45.2M -$35.5M -$107.8M -$10M
Special Dividend Paid $5M -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$107K -- -$29.4M
Other Financing Activities -$1.3M -$4.8M -$3.4M -$2.2M -$624K
Cash From Financing -$105.4M -$50M -$39M -$110M -$40M
 
Beginning Cash (CF) $91.1M $67.8M $106.2M $84.7M $38.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.8M $7.5M $28.8M -$51.6M -$7.7M
Ending Cash (CF) $85.3M $75.4M $135M $33.1M $30.5M
 
Levered Free Cash Flow $73.9M $101.4M $33.1M $5.7M $18.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock